Accessibility Menu
Wellgistics Health logo

Wellgistics Health(NASDAQ) WGRX

Current Price$0.00
Market Cap$9.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-98%
5 YearN/A
1 Year-94%
1 Month+4%
Wellgistics Health last closing stock price
MetricPriceDate
Last closeUSD 3.522026-07-21
Wellgistics Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+20.14%USD 2.932026-07-14
1 month+3.83%USD 3.392026-06-18
3 month-50.07%USD 7.052026-04-22
Year to date-82.38%USD 19.982025-12-31
1 year-94.03%USD 59.002025-07-21
Since inception-98.15%USD 190.502025-02-21

Wellgistics Health Financials at a Glance

Market Cap

$9.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$14.03M

Net Income (TTM)

-$76.59M

EPS (TTM)

-$41.46

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

4,394

Open

$0.00

Previous Close

$3.52

Daily Range

$0.00 - $0.00

52-Week Range

$2.48 - $97.50

Estimated Earnings Date

May 19, 2026

WGRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wellgistics Health

What’s in the Box? (Products and Services)

  • Pharmaceutical Distribution (93.7%): Supplies generic and branded drugs to pharmacies and manufacturers across the U.S.
  • Retail & Specialty Pharmacy (3.7%): Offers pharmacy services for chronic conditions, uninsured patients, and mail order in 32 states and D.C.
  • Third-Party Logistics (2.6%): Provides warehousing, inventory, and shipping for small and mid-size drug makers.
  • DelivMeds Platform: Digital hub for prescription transfers, clinical support, and patient prescription management.

Growth Spurts and Strategic Moves

  • Acquired Wood Sage in June 2024 and Wellgistics LLC in August 2024.
  • DelivMeds digital platform had not yet been placed in service as of December 31, 2025.
  • Expanded manufacturer relationships to over 60 partners and grew pharmacy network to 5,000+ locations.
  • Invested in cold chain logistics and AI-driven prescription routing in 2025.

Why Wellgistics Stands Out (Without the Hype)

Wellgistics combines wholesale, pharmacy, and technology under one roof, serving both drug makers and pharmacies. Its digital platform connects patients, pharmacies, and manufacturers for smoother prescription management. The company targets niche drugs often missed by larger distributors, giving it a unique market position.

Five Things You Need to Know

  • FY2025 net revenue was $23.3 million, up 28.8% from FY2024.
  • Q3 2025 revenue fell 80.9% year-over-year to $3 million.
  • Gross margin dropped to -27.5% in FY2025 from +9.7% in FY2024.
  • Net loss widened to $101,274,530 in FY2025 from $6,856,226 in FY2024.

Bottom Line

Wellgistics has rapidly expanded through acquisitions and technology, but faces financial and operational challenges. Its integrated approach aims to streamline drug distribution for independent pharmacies and manufacturers.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Prashant Patel

Website

www.wellgisticshealth.com

Headquarters

Tampa, FL 33607, US

WGRX Financials

Key Financial Metrics (TTM)

Gross Margin

-69.22%

Operating Margin

-398.05%

Net Income Margin

-545.72%

Return on Equity

1545.09%

Return on Capital

-659.05%

Return on Assets

-254.21%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.63M

Volume

4.39K

Avg. Volume

565.02K

Financials (TTM)

Gross Profit

-$9.71M

Operating Income

-$55.86M

EBITDA

-$54.45M

Operating Cash Flow

-$12.92M

Capital Expenditure

-$187.35K

Free Cash Flow

-$13.11M

Cash & ST Invst.

$51.73K

Total Debt

$28.91M

Wellgistics Health Performance Analysis

Wellgistics Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 18,128,831N/A
20252025-12-31USD 23,337,86028.7%
Wellgistics Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-28.3%
Q32025-09-30-61.3%
Q42025-12-31-44.6%
Q12026-03-31-6.6%
Wellgistics Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.01N/A
20232023-12-31USD -2.7955650.0%
20242024-12-31USD -6.60136.8%
20252025-12-31USD -49.98657.4%
Wellgistics Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3082.3%
Q32025-09-30-318.2%
Q42025-12-3141.3%
Q12026-03-3172.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.56M

-85.6%

Gross Profit

-$186.60K

-126.9%

Gross Margin

-11.97%

N/A

Market Cap

$9.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$298.35K

N/A

Employees

31

N/A

Net Income

-$7.74M

+76.1%

EBITDA

-$5.66M

+81.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$51.73K

-97.9%

Total Debt

$28.91M

+12.3%

Accounts Receivable

$992.15K

-75.0%

Inventory

$1.71M

-82.4%

Long Term Debt

$12.99M

+76.5%

Short Term Debt

$15.92M

-13.4%

Return on Assets

-2.54%

N/A

Return on Invested Capital

26.97%

N/A

Free Cash Flow

-$3.62M

-123.3%

Operating Cash Flow

-$3.41M

-153.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BEATHeartBeam, Inc.
$0.59+4.19%
TELATELA Bio, Inc.
$0.72+0.04%
ALGSAligos Therapeutics, Inc.
$5.44+3.03%
INMBINmune Bio, Inc.
$1.97-1.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$35.14+0.24%
SKHYSK Hynix
$171.94+0.14%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.31-0.06%
NOKNokia
$10.63+0.05%

Questions About WGRX

What is the current price of Wellgistics Health?

Wellgistics Health is trading at $0.00 per share.

What is the 52-week range for Wellgistics Health?

Over the past 52 weeks, Wellgistics Health has traded between $2.48 and $97.50.

How much debt does Wellgistics Health have?

As of the most recent reporting period, Wellgistics Health reported total debt of $28.91M.

How much cash does Wellgistics Health have on hand?

Wellgistics Health reported $51.73K in cash and cash equivalents in its most recent financial results.

What is Wellgistics Health’s dividend yield?

Wellgistics Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services